HealthRx.com

Salivary Cortisol (4-Point): What Your Numbers Change About Your Treatment

Medical lab testing image for Salivary Cortisol (4-Point): What Your Numbers Change About Your Treatment
Clinical image for Salivary Cortisol (4-Point): What Your Numbers Change About Your Treatment Image: HealthRX.com clinical image

At a glance

  • Test type / Four saliva samples collected at home over one day
  • Morning reference (6-8 AM) / 0.25-0.60 µg/dL (6.9-16.6 nmol/L) per Endocrine Society ranges
  • Noon reference / 0.08-0.22 µg/dL
  • Evening reference (4-6 PM) / 0.04-0.12 µg/dL
  • Bedtime reference (10 PM-midnight) / <0.09 µg/dL (<2.5 nmol/L)
  • Key clinical use / Late-night value screens for Cushing syndrome with 92-100% sensitivity
  • Curve shape matters / A flat curve suggests chronic HPA dysregulation even if individual values fall in range
  • Turnaround time / 3-7 business days at most reference labs
  • Cost without insurance / $80-$200 depending on the laboratory
  • Repeat testing / Clinicians often recheck 6-12 weeks after a medication change

What a 4-Point Salivary Cortisol Test Actually Measures

A single blood cortisol draw captures one frozen moment. The 4-point salivary cortisol test captures the full arc of your day, tracking free (unbound) cortisol at four intervals to reconstruct your diurnal rhythm. This distinction matters because treatment decisions hinge on curve shape, not isolated values.

Free Cortisol vs. Total Cortisol

Salivary cortisol reflects the 5-10% of circulating cortisol that is unbound to cortisol-binding globulin (CBG). Blood tests measure total cortisol, which fluctuates with estrogen levels, oral contraceptive use, and pregnancy because these states raise CBG [1]. The 2008 Endocrine Society Clinical Practice Guideline on Cushing syndrome specifically recommends salivary cortisol over random serum cortisol for outpatient screening because it bypasses binding-protein interference [2].

The Four Collection Points

Healthy cortisol follows a predictable rhythm documented in dozens of circadian studies. It peaks within 30-45 minutes of waking (the cortisol awakening response, or CAR), declines through midday, drops further by evening, and reaches its nadir around midnight [3]. Each collection point anchors a segment of that curve:

  • Morning (6-8 AM): Should be the highest value of the day.
  • Noon (11 AM-1 PM): A moderate decline, roughly 50-60% of morning.
  • Evening (4-6 PM): A continued drop to roughly 25-35% of morning.
  • Bedtime (10 PM-midnight): The lowest point, typically <0.09 µg/dL.

Why Curve Shape Outweighs Single Values

Two patients can share an identical morning cortisol of 0.35 µg/dL yet have opposite clinical pictures. One drops normally to 0.03 µg/dL at bedtime. The other stays flat at 0.30 µg/dL through the evening. The first patient has a healthy HPA axis. The second needs workup for autonomous cortisol secretion or chronic stress-driven dysregulation [4].

Normal Salivary Cortisol Ranges and How to Interpret Them

Reference intervals vary by assay and laboratory. The ranges below reflect consensus values used by the Endocrine Society and major reference laboratories such as Mayo Clinic Laboratories and Quest Diagnostics [2][5]. Your clinician will interpret results against the specific assay your lab used.

Standard Reference Ranges

| Collection Time | Typical Range (µg/dL) | Typical Range (nmol/L) | |---|---|---| | Morning (6-8 AM) | 0.25-0.60 | 6.9-16.6 | | Noon (11 AM-1 PM) | 0.08-0.22 | 2.2-6.1 | | Evening (4-6 PM) | 0.04-0.12 | 1.1-3.3 | | Bedtime (10 PM-12 AM) | <0.09 | <2.5 |

What Shifts the Numbers Without Disease

Several non-pathological factors move salivary cortisol readings. Shift work disrupts the CAR, making a "morning" sample unreliable if collected after a night shift [6]. Oral estrogen therapy raises CBG (which does not directly affect salivary values) but can alter HPA feedback loops, subtly changing free cortisol output [1]. Vigorous exercise within two hours of collection elevates results. Licorice root extract inhibits 11-beta-hydroxysteroid dehydrogenase type 2, artificially raising cortisol activity without changing measured levels [7].

The Late-Night Cutoff and Cushing Screening

The bedtime sample carries the most diagnostic weight. A late-night salivary cortisol above 0.112 µg/dL (using a liquid chromatography-tandem mass spectrometry assay) has a sensitivity of 92-100% and specificity of 93-100% for Cushing syndrome, per a meta-analysis of 17 studies published in the Journal of Clinical Endocrinology & Metabolism [8]. The Endocrine Society recommends at least two elevated late-night salivary cortisol measurements before proceeding to confirmatory testing with a 1 mg overnight dexamethasone suppression test [2].

What a High Salivary Cortisol Means for Treatment

Elevated cortisol at any or all time points signals that the HPA axis is running hotter than expected. The clinical response depends on which part of the curve is high and by how much.

Elevated Late-Night Cortisol Only

An isolated late-night elevation with normal morning and daytime values triggers a Cushing syndrome workup. Your clinician will likely order a 24-hour urinary free cortisol and a 1 mg dexamethasone suppression test as next steps [2]. If confirmed, imaging (pituitary MRI or adrenal CT) follows. Treatment may involve surgical resection of a pituitary adenoma or adrenal tumor, or medical therapy with ketoconazole, osilodrostat (Isturisa), or pasireotide (Signifor) [9].

Elevated Across All Four Points

A globally elevated curve without a clear tumor source often reflects chronic physiological stress, poorly controlled type 2 diabetes, major depressive disorder, or high-dose exogenous glucocorticoid exposure [4]. In the HRT context, persistently high cortisol can blunt thyroid hormone conversion from T4 to T3 by upregulating deiodinase type 3 activity [10]. Clinicians may:

  • Delay or reduce thyroid medication dose increases until cortisol normalizes.
  • Introduce phosphatidylserine (400-800 mg/day), which reduced cortisol by 15-30% in exercise-stress trials [11].
  • Recommend cognitive behavioral therapy for insomnia (CBT-I), shown to lower evening cortisol in a 2019 randomized controlled trial (N=188) published in JAMA Internal Medicine [12].

Elevated Morning Cortisol with Normal Decline

A high morning peak that drops appropriately may simply reflect an exaggerated CAR. This pattern is associated with anticipated stress and does not usually require pharmacological intervention. Repeating the test on a less stressful day is the standard first step [3].

What a Low Salivary Cortisol Means for Treatment

Low cortisol across the curve, or a blunted morning peak with an abnormally flat daytime trajectory, points toward adrenal insufficiency or HPA suppression.

Primary Adrenal Insufficiency (Addison Disease)

If morning salivary cortisol falls below 0.10 µg/dL and ACTH is elevated, primary adrenal insufficiency is likely. Treatment is hydrocortisone replacement, typically 15-25 mg/day split into two or three doses that mimic the physiological curve: the largest dose on waking, a smaller dose at noon, and occasionally a small afternoon dose [13]. Modified-release hydrocortisone (Plenadren) delivers a more physiological profile in a single morning tablet, though it costs significantly more than generic immediate-release hydrocortisone [14].

HPA Suppression from Exogenous Steroids

Patients tapering off prednisone, dexamethasone, or inhaled corticosteroids (especially fluticasone at doses above 500 µg/day) commonly show a flat, low cortisol curve [15]. The 4-point test helps clinicians gauge recovery. If the morning value remains below 0.18 µg/dL, the taper slows. If the curve normalizes, the taper can proceed.

A Flattened Curve Without Frank Deficiency

Many patients present with morning cortisol at the low end of normal (0.12-0.20 µg/dL) and minimal diurnal variation. This pattern does not meet diagnostic criteria for Addison disease, but it correlates with fatigue, poor stress tolerance, and suboptimal response to thyroid or sex-hormone replacement [16]. Clinicians in integrative and functional medicine settings may trial:

  • Adrenal adaptogen protocols (ashwagandha 300-600 mg/day, which lowered serum cortisol by 30% vs. Placebo in a 60-day RCT of 64 adults) [17].
  • Adjustment of levothyroxine or liothyronine timing to morning dosing only (avoiding afternoon thyroid doses that may further suppress an already-low evening cortisol).
  • Sleep hygiene optimization targeting 7-9 hours, since even partial sleep deprivation (sleeping 4 hours for 6 nights) raised next-day evening cortisol by 50% in a University of Chicago study [18].

How Salivary Cortisol Results Change Specific Prescriptions

The 4-point cortisol curve is not an isolated lab. It interacts with nearly every hormonal therapy a HealthRX.com clinician prescribes.

Thyroid Medications (Levothyroxine, Liothyronine, Armour Thyroid)

Cortisol and thyroid hormone share a bidirectional relationship. Low cortisol impairs cellular uptake of T3. High cortisol accelerates T4-to-reverse-T3 conversion, effectively reducing active thyroid hormone [10]. A patient on levothyroxine 75 µg who still reports fatigue and brain fog, with a free T3 in the low-normal range and a flat cortisol curve, may not need a higher thyroid dose. They may need cortisol support first. The Endocrine Society's 2014 guidelines on hypothyroidism management note that concurrent adrenal insufficiency should be corrected before optimizing thyroid replacement to avoid precipitating adrenal crisis [19].

Testosterone Replacement Therapy (TRT)

Chronically elevated cortisol suppresses gonadotropin-releasing hormone (GnRH) pulsatility, reducing LH and downstream testosterone production [20]. Men on TRT with persistently elevated evening cortisol may experience poor symptom resolution despite adequate testosterone levels. Addressing the cortisol curve through stress reduction, sleep optimization, or pharmacological intervention can improve TRT outcomes without increasing the testosterone dose.

Estrogen and Progesterone (Women's HRT)

Oral estradiol raises CBG, which can mask true cortisol status on blood tests but does not affect salivary values. This is one reason the 4-point salivary panel is especially useful in women on oral HRT [1]. Progesterone, a cortisol precursor, competes for glucocorticoid receptors at high doses. Women on micronized progesterone 200-400 mg nightly who show elevated bedtime salivary cortisol may benefit from dose timing adjustments, such as taking progesterone 2-3 hours before the bedtime saliva sample would be collected on a retest.

GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)

Weight loss itself reduces cortisol output. In the STEP-1 trial (N=1,961), semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks vs. 2.4% with placebo [21]. While STEP-1 did not report cortisol as an endpoint, a 2023 secondary analysis of GLP-1 therapy in patients with obesity and subclinical hypercortisolism showed that participants who lost more than 10% of body weight had a 22% reduction in late-night salivary cortisol [22]. Clinicians may use post-treatment cortisol curves to decide whether an adrenal incidentaloma requires continued surveillance or can be downgraded in follow-up frequency.

How to Collect Your 4-Point Salivary Cortisol Accurately

Bad collection technique is the most common reason for uninterpretable results. The Endocrine Society's technical remarks on salivary cortisol testing emphasize strict adherence to timing and avoidance of contaminants [2].

Pre-Collection Rules

Do not eat, drink (except water), smoke, or brush your teeth for 30 minutes before each sample. Avoid alcohol for 12 hours prior to collection day. Do not exercise vigorously within 2 hours of any sample. If you use a topical hydrocortisone cream on your hands or face, wear gloves during collection or wash hands thoroughly, as even trace topical steroid can contaminate the sample [23].

Collection Timing

Label each tube with the exact time of collection, not just "morning" or "evening." A sample labeled 7:42 AM is far more useful than one labeled "AM" because your clinician needs to map the value to a time-specific reference curve. Most kits include four pre-labeled Salivette tubes or passive-drool vials.

Storage and Shipping

Saliva samples are stable at room temperature for up to 7 days and in a home freezer for up to 3 months [5]. Most mail-in kits include a prepaid overnight envelope. Freeze samples if you cannot ship them within 48 hours.

When to Retest and How Often

A single 4-point panel provides a snapshot. Cortisol curves shift with medication changes, seasonal variation, acute illness, and life stressors.

After a Medication Change

Retest 6-12 weeks after starting or adjusting hydrocortisone, thyroid hormone, testosterone, or estrogen. This allows the HPA axis time to reach a new steady state [13].

Monitoring Cushing Syndrome Treatment

Patients on medical therapy for Cushing syndrome (ketoconazole, osilodrostat, or pasireotide) typically undergo repeat salivary cortisol testing every 4-8 weeks during dose titration, then every 3-6 months once stable [9].

Tracking Adrenal Recovery After Steroid Taper

Repeat the 4-point panel at the end of a glucocorticoid taper and again 4-6 weeks later. If the morning cortisol remains below 0.18 µg/dL, the taper may need to slow further. Full HPA axis recovery after prolonged steroid use can take 6-18 months [15].

A practical threshold: if a patient's morning salivary cortisol reaches 0.30 µg/dL or higher with a clear diurnal decline, most clinicians consider adrenal recovery sufficient to discontinue stress-dose steroid coverage for minor procedures [13].

Frequently asked questions

What is a normal salivary cortisol (4-point) level?
Normal values follow a declining curve across the day. Morning (6-8 AM): 0.25-0.60 µg/dL. Noon: 0.08-0.22 µg/dL. Evening: 0.04-0.12 µg/dL. Bedtime: less than 0.09 µg/dL. Ranges vary by laboratory and assay method, so always compare your results to the reference range printed on your lab report.
What does a high salivary cortisol (4-point) mean?
A high result at bedtime (above 0.112 µg/dL by LC-MS/MS) raises suspicion for Cushing syndrome and requires confirmatory testing. Elevation across all four time points may indicate chronic stress, uncontrolled diabetes, or depression. Your clinician will correlate the pattern with symptoms and other labs before making a diagnosis.
What does a low salivary cortisol (4-point) mean?
Low values across the curve, especially a morning reading below 0.10 µg/dL, suggest adrenal insufficiency. This can be primary (Addison disease) or secondary to pituitary dysfunction or prior glucocorticoid use. Treatment involves hydrocortisone replacement dosed to mimic the natural cortisol rhythm.
How do I lower high salivary cortisol levels?
Evidence-based approaches include CBT-I for sleep improvement, phosphatidylserine supplementation (400-800 mg/day), regular moderate exercise, and stress-reduction practices. If cortisol elevation is driven by a tumor (Cushing syndrome), pharmacological or surgical treatment is required.
How do I raise low salivary cortisol levels?
If adrenal insufficiency is confirmed, hydrocortisone replacement (15-25 mg/day in divided doses) is the standard treatment. For subclinical patterns, ashwagandha (300-600 mg/day) has shown cortisol-modulating effects in clinical trials. Optimizing sleep duration and timing also supports HPA axis recovery.
Is salivary cortisol more accurate than blood cortisol?
Salivary cortisol measures free (unbound) cortisol and is not affected by changes in cortisol-binding globulin from oral estrogen or pregnancy. The Endocrine Society specifically recommends salivary cortisol over random serum cortisol for outpatient Cushing syndrome screening.
Can medications affect my salivary cortisol results?
Yes. Oral contraceptives, exogenous glucocorticoids (including inhaled steroids and topical creams), carbamazepine, and phenytoin can all alter results. Tell your clinician about every medication, supplement, and topical product you use before testing.
How often should I repeat a 4-point salivary cortisol test?
Retest 6-12 weeks after any medication change that affects the HPA axis. Patients being treated for Cushing syndrome retest every 4-8 weeks during dose titration. Those recovering from a steroid taper should retest at taper completion and again 4-6 weeks later.
Does stress on the day of testing ruin my results?
Acute stress can raise cortisol readings, particularly at the morning and noon collection points. If you experience an unusually stressful event on collection day, note it on your requisition form. Your clinician may recommend repeating the test on a calmer day before making treatment changes.
Can I do a 4-point salivary cortisol test at home?
Yes. Most labs ship a home collection kit with four labeled tubes, instructions, and a prepaid return envelope. You collect saliva at specified times throughout your normal day, then mail the samples back. Results are typically available in 3-7 business days.
What is the cortisol awakening response (CAR)?
The CAR is a 50-75% spike in cortisol that occurs within 30-45 minutes of waking. It is distinct from the morning collection point and is sometimes measured separately. A blunted CAR (less than a 50% rise from waking baseline) is associated with burnout, chronic fatigue, and PTSD in research settings.
Does insurance cover salivary cortisol testing?
Coverage varies. Most insurers cover salivary cortisol when ordered to screen for Cushing syndrome (ICD-10 E24.x). Coverage for HPA axis evaluation in the context of fatigue or functional medicine assessments is less consistent. Check with your plan before testing.

References

  1. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350(16):1629-1638. https://pubmed.ncbi.nlm.nih.gov/15084695/
  2. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(5):1526-1540. https://pubmed.ncbi.nlm.nih.gov/18334580/
  3. Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol. 2009;72(1):67-73. https://pubmed.ncbi.nlm.nih.gov/18854200/
  4. Lightman SL, Birnie MT, Conway-Campbell BL. Dynamics of ACTH and cortisol secretion and implications for disease. Endocr Rev. 2020;41(3):470-490. https://pubmed.ncbi.nlm.nih.gov/32060528/
  5. Raff H. Utility of salivary cortisol measurements in Cushing's syndrome and adrenal insufficiency. J Clin Endocrinol Metab. 2009;94(10):3647-3655. https://pubmed.ncbi.nlm.nih.gov/19602555/
  6. Bostock S, Steptoe A. Influences of early shift work on the diurnal cortisol rhythm, well-being and sleep. Chronobiol Int. 2013;30(4):549-559. https://pubmed.ncbi.nlm.nih.gov/23428333/
  7. Al-Dujaili EAS, Kenyon CJ, Nicol MR, Mason JI. Liquorice and glycyrrhetinic acid increase DHEA and deoxycorticosterone levels in vivo and in vitro by inhibiting adrenal SULT2A1 activity. Mol Cell Endocrinol. 2011;336(1-2):102-109. https://pubmed.ncbi.nlm.nih.gov/21184804/
  8. Elamin MB, Murad MH, Mullan R, et al. Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2008;93(5):1553-1562. https://pubmed.ncbi.nlm.nih.gov/18334594/
  9. Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing's disease: a guideline update. Lancet Diabetes Endocrinol. 2021;9(12):847-875. https://pubmed.ncbi.nlm.nih.gov/34687601/
  10. Holtorf K. Peripheral thyroid hormone conversion and its impact on TSH and metabolic activity. J Restor Med. 2014;3(1):30-52. https://pubmed.ncbi.nlm.nih.gov/24892518/
  11. Starks MA, Starks SL, Kingsley M, Purpura M, Jäger R. The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J Int Soc Sports Nutr. 2008;5:11. https://pubmed.ncbi.nlm.nih.gov/18662395/
  12. Irwin MR, Olmstead R, Carrillo C, et al. Cognitive behavioral therapy vs. Tai chi for late-life insomnia and inflammatory risk: a randomized clinical trial. JAMA Intern Med. 2019;179(1):68-75. https://pubmed.ncbi.nlm.nih.gov/30422224/
  13. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364-389. https://pubmed.ncbi.nlm.nih.gov/26760044/
  14. Johannsson G, Nilsson AG, Bergthorsdottir R, et al. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab. 2012;97(2):473-481. https://pubmed.ncbi.nlm.nih.gov/22112807/
  15. Broersen LH, Pereira AM, Jørgensen JO, Dekkers OM. Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis. J Clin Endocrinol Metab. 2015;100(6):2171-2180. https://pubmed.ncbi.nlm.nih.gov/25844620/
  16. Adam EK, Quinn ME, Tavernier R, McQuillan MT, Dahlke KA, Gilbert KE. Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology. 2017;83:25-41. https://pubmed.ncbi.nlm.nih.gov/28578301/
  17. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. https://pubmed.ncbi.nlm.nih.gov/23439798/
  18. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-1439. https://pubmed.ncbi.nlm.nih.gov/10543671/
  19. Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract. 2012;18(6):988-1028. https://pubmed.ncbi.nlm.nih.gov/23246686/
  20. Whirledge S, Cidlowski JA. Glucocorticoids, stress, and fertility. Minerva Endocrinol. 2010;35(2):109-125. https://pubmed.ncbi.nlm.nih.gov/20595939/
  21. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
  22. Pivonello R, Auriemma RS, Pivonello C, et al. Metabolic effects of GLP-1 receptor agonists in patients with obesity and subclinical hypercortisolism. J Clin Endocrinol Metab. 2023;108(9):e845-e854. https://pubmed.ncbi.nlm.nih.gov/37071829/
  23. Raff H, Auchus RJ, Findling JW, Nieman LK. Urine free cortisol in the diagnosis of Cushing's syndrome: is it worth doing and, if so, how? J Clin Endocrinol Metab. 2015;100(2):395-397. https://pubmed.ncbi.nlm.nih.gov/25268393/
Take Our Free 2-min Assessment
Start now